Kawasumi Laboratories, Incorporated【JP:E02310】
Market cap
P/E ratio
| Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | |
| Net sales | 27,830 | 27,625 | 28,408 | 28,135 | 24,726 | 25,437 | 24,104 | 22,323 |
| Cost of sales | 19,289 | 18,617 | 18,878 | 18,006 | 15,865 | 16,754 | 15,896 | 14,772 |
| Gross profit (loss) | 8,540 | 9,008 | 9,529 | 10,129 | 8,861 | 8,682 | 8,208 | 7,551 |
| Selling, general and administrative expenses | 8,121 | 8,402 | 8,123 | 7,999 | 7,937 | 7,995 | 7,609 | 6,903 |
| Operating profit (loss) | 419 | 606 | 1,406 | 2,130 | 923 | 687 | 598 | 648 |
| Interest income | 18 | 9 | 14 | 31 | 35 | 40 | 49 | 44 |
| Dividend income | 19 | 16 | 25 | 35 | 33 | 40 | 60 | 43 |
| Foreign exchange gains | 231 | 101 | 285 | - | - | - | 22 | - |
| Share of profit of entities accounted for using equity method | 5 | - | 17 | 41 | 56 | 15 | 13 | 14 |
| Foreign exchange gains | 231 | 101 | 285 | - | - | - | 22 | - |
| Revenue of scraps | 53 | 49 | 62 | 50 | 40 | 47 | 52 | 61 |
| Other | 94 | 113 | 40 | 14 | 48 | 22 | 16 | 17 |
| Other | 94 | 113 | 40 | 14 | 48 | 22 | 16 | 17 |
| Non-operating income | 549 | 393 | 445 | 172 | 214 | 208 | 215 | 180 |
| Non-operating income | 549 | 393 | 445 | 172 | 214 | 208 | 215 | 180 |
| Interest expenses | 19 | 45 | 2 | 1 | 1 | 1 | 1 | 1 |
| Foreign exchange losses | - | - | - | 111 | 102 | 96 | - | 8 |
| Depreciation | 26 | 358 | - | - | - | 5 | 21 | 20 |
| Other | 93 | 25 | 14 | 12 | 10 | 8 | 2 | 3 |
| Non-operating expenses | 140 | 446 | 16 | 125 | 114 | 107 | 25 | 33 |
| Ordinary profit (loss) | 828 | 552 | 1,835 | 2,177 | 1,023 | 788 | 787 | 795 |
| Gain on sales of non-current assets | 1 | 2 | 2 | 19 | 12 | 1 | 58 | 203 |
| Gain on sales of investment securities | 8 | - | - | - | 25 | - | 1,245 | 1,063 |
| Extraordinary income | 1,191 | 2,839 | 2 | 19 | 38 | 1 | 1,303 | 1,267 |
| Loss on sales and retirement of non-current assets | 71 | 114 | 8 | 35 | 44 | 56 | 10 | 14 |
| Restructuring expenses | - | - | - | - | - | - | 1,671 | 58 |
| Impairment loss | - | 2,189 | 80 | - | - | - | - | 19 |
| Loss on valuation of inventories | - | - | - | - | - | - | - | 30 |
| Loss on valuation of inventories | - | - | - | - | - | - | - | 30 |
| Extraordinary losses | 687 | 2,307 | 89 | 35 | 44 | 56 | 1,681 | 122 |
| Extraordinary losses | 687 | 2,307 | 89 | 35 | 44 | 56 | 1,681 | 122 |
| Profit (loss) before income taxes | 1,332 | 1,085 | 1,749 | 2,160 | 1,017 | 733 | 409 | 1,940 |
| Income taxes - current | 477 | 740 | 554 | 570 | 77 | 250 | 238 | 502 |
| Income taxes - deferred | 19 | -284 | 191 | -38 | 60 | 33 | -18 | 38 |
| Income taxes | 497 | 456 | 745 | 965 | -123 | 283 | 220 | 541 |
| Profit (loss) | - | - | 1,003 | 1,194 | 1,140 | 449 | 188 | 1,399 |
| Profit (loss) attributable to non-controlling interests | - | - | 27 | 27 | 24 | 9 | 1 | 4 |
| Profit (loss) attributable to owners of parent | - | - | 975 | 1,167 | 1,116 | 440 | 186 | 1,395 |